Ann Marie Stewart

Ann Marie Stewart serves as a Contracting Officer for the Department of Veterans Affairs’ RPO East (36C24E), where she leads the acquisition of high-complexity scientific and technical services critical to advancing veteran health outcomes. Her portfolio centers on biomedical research, precision medicine, and advanced laboratory analytics, with a focus on genomics, metabolomics, and bioinformatics. She manages full and open competitions for mission-critical contracts that support the Million Veteran Program and data-driven clinical research initiatives, ensuring compliance with federal procurement regulations while prioritizing scientific rigor and technical innovation. Stewart maintains strategic relationships with leading providers in life sciences and research support, including TEMPUS AI, INC, INFINITY BIOLOGIX LLC, BOOZ ALLEN HAMILTON INC, COMMONWEALTH HOME HEALTH CARE, INC., and METABOLON, INC. These partnerships reflect her emphasis on vendors with deep expertise in analytical instrumentation, clinical data interpretation, and translational research services. Her contracting approach favors established contractors with proven capabilities in complex scientific environments, often requiring specialized certifications and compliance with HIPAA, CLIA, and FDA standards. Her set-aside preferences are overwhelmingly aligned with full and open competition, with only 1% of awards designated for service-disabled veteran-owned small businesses. This reflects the highly specialized nature of the services procured, where technical expertise often exceeds small business capacity, though she remains committed to equitable opportunity within the constraints of mission requirements. Stewart’s primary NAICS focus includes 541720 (social sciences R&D), 334516 (analytical laboratory instrument manufacturing), and 541715 (physical and life sciences R&D), underscoring her expertise in procuring next-generation diagnostic tools, laboratory automation systems, and bioinformatic analysis platforms. She routinely handles acquisitions for next-generation sequencing, mass spectrometry, and AI-enabled clinical data platforms, ensuring the VA maintains a cutting-edge research infrastructure to improve veteran care.